Cardiology

Cardiology, Diet, Featured, Gastroenterology, Metabolic syndrome, Pharmaceuticals
Varying microbiome composition may explain differences in statin efficacy

A new study’s mix of microbiome and genetic data yields fascinating new insights into possible precision medicine treatment techniques for cardiovascular disease. According to researchers at the Institute for Systems

Biotechnology, Cardiology, Diabetes, Diet, Featured, Longevity, Metabolic syndrome, World health
Lipodomic analysis identifies new lipid biomarkers for heart disease and type 2 diabetes

Researches from Deutsches Zentrum fuer Diabetesforschung (DZD), have identified new lipid biomarkers for CVD and T2D using lipodomic analysis. The team also found that increasing unsaturated fatty acid intake reduced

Biotechnology, Cancer, Cardiology, Genetics, Med Lifestyle, Medical News, Pharmaceuticals
New drug delivery system shown to effectively deliver therapeutic levels of gene-editing proteins

A Harvard research team has developed a new generation of virus-like particles, capable of delivering gene-editing proteins with high-specificity.

Cardiology, Diet, Gastroenterology, Med Lifestyle, Medical News, Metabolic syndrome, Obesity, Pediatrics, World health
Adolescent obesity associated with abnormal heart development

A King’s College research team found abnormal cardiac development associated with childhood obesity. These abnormalities included a tilted left ventricle, an asymmetry commonly associated with aortic stenosis patients. Rising obesity

Biotechnology, Cardiology, Medical News
Sensors developed that can detect the electrical activity of a single cardiac cell

The first-of-its-kind nanotechnology is capable of measuring signals within individual cells, as well as between cells. The device even found that signals moving within individual cardiac cells move nearly five

Cardiology, Diabetes, Diet, Longevity, Medical News, Metabolic syndrome, World health
New study suggests apoB/apoA-1 ratio as an accurate marker for cardiovascular disease

Patients with the highest apoB/apoA-1 levels had a 70% increased risk of severe cardiovascular disease. Overall, the findings suggest that the apoB/apoA-1 ratio is a superior marker for identifying more